Acquired glucose 6-phosphate dehydrogenase (G6PD) deficiency in a patient with Chronic Myelomonocytic Leukemia

Br J Haematol. 2022 May;197(4):e45-e48. doi: 10.1111/bjh.18037. Epub 2022 Jan 6.

Authors

Anne-Sophie Naville¹, Estibaliz Lazaro², Julian Boutin^{3

4

5}, Camille Prot-Leurent², Olivier Mansier¹, Emmanuel Richard^{3

4

5}, Vanessa Augis¹, Laurent Weinmann¹, Valerie Fuster¹, Jean-Philippe Vial¹, Cecile Ged^{3

4

5}, Stephanie Dulucq¹

Affiliations

¹ Laboratory of Haematology, University Hospital of Bordeaux, Bordeaux, France.
² Internal medicine department, University Hospital of Bordeaux, Bordeaux, France.
³ Laboratory of Biochemistry, University Hospital of Bordeaux, Bordeaux, France.
⁴ INSERM, BMGIC, University of Bordeaux, Bordeaux, France.
⁵ Laboratory of Excellence Gr-Ex, Paris, France.

PMID: 34989400
DOI: 10.1111/bjh.18037

No abstract available

Keywords: G6PD; acquired deficiencies; genetic confirmation; pyruvate kinase; red cell enzymopathies.

Publication types

Letter

MeSH terms

Erythrocytes
Glucose
Glucosephosphate Dehydrogenase
Glucosephosphate Dehydrogenase Deficiency* / complications
Glucosephosphate Dehydrogenase Deficiency* / genetics
Humans
Leukemia, Myelomonocytic, Chronic* / complications
Leukemia, Myelomonocytic, Juvenile*
Oxidoreductases
Phosphates

Substances

Phosphates
Oxidoreductases
Glucosephosphate Dehydrogenase
Glucose